Exhibit 10.1

 

Orchid BioSciences, Inc.

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (the “Agreement”) is entered into between Orchid
BioSciences, Inc., a Delaware corporation (the “Company”), and Raymond J. Land
(the “Employee”), on April 25, 2005, in consideration of, and as a condition of,
Employee’s employment by Company and of the compensation to be paid to Employee
by Company, and in recognition of the fact that Employee will have access to the
Company’s confidential, proprietary, and trade secret information, and therefore
Company and Employee agree to the terms and conditions set forth in this
agreement as follows:

 

1. Position. The Company and the Employee agree that Employee will serve as
Senior Vice President and Chief Financial Officer of the Company, based at the
Company’s Head office. Employee agrees that Employee’s employment with the
Company is on an at will basis, is for no specified term and may be terminated
by the Company at any time, with or without Cause (as defined in Section 3
herein). Similarly, Employee may terminate employment with the Company at any
time, for any reason upon written notice as provided in Section 3 of this
Agreement. Employee understands and agrees that the at will nature of Employee’s
employment relationship with Company cannot be changed or modified. The
Employee’s performance will be reviewed formally on an annual basis in
conjunction with an annual salary period. The Company’s obligations under this
Agreement shall be subject to the Company’s receipt of references regarding the
Employee satisfactory to the Company in its sole discretion.

 

2. Employment Date: Nature of Relationship. Employee’s employment with the
Company will begin on June 6, 2005 (the “Employment Date”). The Employee will
perform for the Company such duties that are customarily assigned to his
position and as may be designated by the Company from time to time. The Employee
will be expected to devote all of his working time to the performance of his
duties with the Company.

 

3. Termination. Without in any way limiting the at will basis of Employee’s
employment by the Company, Employee’s employment hereunder shall terminate upon
the occurrence of any of the following events:

 

(a) The death of Employee;

 

(b) Written notice of termination from the Company to Employee that Employee’s
employment is being terminated as a result of Employee’s incapacity or inability
to further perform services as contemplated herein for ninety (90) consecutive
days or more within any six-month period, because Employee’s physical or mental
health has become so impaired as to make it impossible or impractical for
Employee to perform the duties and responsibilities contemplated hereunder
(determination of the Employee’s physical or mental health will be determined by
a medical expert appointed by mutual agreement between the Company and the
Employee);

 

(c) Written notice of termination from the Company to Employee that Employee’s
employment is being terminated for Cause (as hereafter defined). “Cause” shall
mean that either the Employee has (1) intentionally committed an act or omission
that materially harms the Company; (2) been grossly negligent in performance of
his duty to the Company, which is

 

 

--------------------------------------------------------------------------------

incapable of cure or not cured within ten (10) business days after the date of
receipt by Employee of notice of its existence; (3) committed an act of moral
turpitude; (4) committed an act of fraud or material dishonesty in discharging
his duties to the Company; (5) materially breached this Agreement or any other
employment agreement or any consulting, advisory, nondisclosure, non-competition
or similar agreement between the Employee and the Company, or breached any code
of conduct or ethics or similar policy in effect at the Company, as all of the
foregoing may be amended from time to time or (6) engaged in any other act or
commission that may be deemed grounds for a “cause” termination under Delaware
state law.

 

(d) Written notice of termination from the Company to Employee that Employee’s
employment is being terminated without Cause;

 

(e) Employee’s written notice of resignation to the Company due to a
Constructive Dismissal (as hereafter defined). A “Constructive Dismissal” shall
mean the occurrence, without Employee’s express written consent, of any of the
following: (i) a substantial diminution in the nature or status of Employee’s
position, authority, or primary duties or responsibilities; or (ii) a material
breach by the Company of this Agreement; provided, there shall be no
Constructive Dismissal unless the Employee provides the Board of Directors and
the Chief Executive Officer with written notice reasonably detailing the
purported basis for the Constructive Dismissal and the Company fails to remedy
within sixty (60) business days after its receipt of such notice;

 

(f) Employee’s written notice of resignation to the Company for any reasons
other than due to a Constructive Dismissal or Change of Control (as hereinafter
defined); or

 

(g) Written notice of termination from the Company to Employee that Employee’s
employment is being terminated as a result of a Change of Control within six (6)
months following the Change of Control. For the purposes of this Agreement,
Change of Control is:

 

(i) Ownership. Any “Person” (as such terms is used in Sections 13(d) and 14(d)
of the Securities Exchange Act of 1934, as amended) becomes the “Beneficial
Owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of
securities of the Company representing 50% (fifty percent) or more of the total
voting power represented by the Company’s then outstanding voting securities
(excluding for this purpose the Company or its Affiliates or any employee
benefit plan of the Company).

 

(ii) Merger/Sale of Assets. A merger or consolidation of the Company whether or
not approved by the Board of Directors, other than a merger or consolidation
which would result in the voting securities of the Company outstanding
immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into voting securities of the surviving entity
or the parent of such corporation) at least 50% (fifty percent) of the total
voting power represented by the voting securities of the Company or such
surviving entity or parent of such corporation outstanding immediately after
such merger or consolidation, or the consummation of an agreement for the sale
or disposition of the Company of all or substantially all of the Company’s
assets. “Substantially all of the Company’s assets” shall be deemed to include
the assets of all business units and/or divisions of the Company and all of its
affiliates.

 

2

--------------------------------------------------------------------------------

(h) Company notifies the Employee that the Company’s Corporate offices in
Princeton, NJ will be moved more than 50 miles from its present location.

 

4. Payment After Termination. Following termination of Employee’s employment,
all payments and benefits provided to Employee under this Agreement shall cease
as of the date of such termination, except that in the event Employee’s
employment is terminated (i) by Employee pursuant to Section 3(e), or (ii) by
the Company pursuant to Sections 3(d), (g) or (h), then (X) for a period of
twelve (12) months after the date of such termination, the Company shall: (a)
pay Employee severance pay in the form of continuation of Employee’s base
salary, less standard deduction and withholdings, such payments to be made at
the same time as Employee’s salary otherwise would have been payable, and (b) if
Employee elects continued coverage under COBRA, the Company will reimburse
Employee for the same portion of Employee’s health insurance premiums for
Employee and Employee’s family, to the same extent the Company paid those
premiums during Employee’s employment; and (Y) at the end of such twelve (12)
month period, the Company shall pay to Employee an amount equal to a prorated
portion of Employee’s bonus determined from January 1 of the year his employment
terminated through the date of termination, less standard deductions and
withholdings.

 

5. Compensation, Equity and Benefits

 

(a) The Employee’s initial base pay shall be at an annualized rate of Two
Hundred and Seventy Five Thousand Dollars ($275,000) per year, minus customary
deductions for federal and state taxes and the like. The Chief Executive Officer
will review the Employee’s base pay rate on an annual basis, during the first
calendar quarter of each year, with any increase becoming effective as of April
1. The Employee will also be eligible to receive an Annual Performance Bonus in
accordance with the Company’s Bonus Plan for each calendar year the Employee is
employed by the Company, in accordance with the Company’s Bonus Plan in effect
for such year. The Employee must be employed by the Company on the date of
payment of the Annual Performance Bonus to be entitled to receive such Bonus.
The award and amount of any Annual Performance Bonus shall be determined by the
Chief Executive Officer and the Board based on the Employee’s performance and
the overall performance of the Company, measured against goals that are
established by the Company from time to time. The bonus target for each year
will be forty percent (40%) of the Employee’s annualized base pay rate, and the
amount of any Annual Bonus for 2005 shall be prorated based on the number of
full months in 2005 in which the Employee is employed by the Company.

 

(b) The Company will grant to the Employee incentive stock options to purchase
forty thousand (40,000) shares of the common stock of the Company at an exercise
price equal to the closing price of such stock on the Employment Date, all of
which will be immediately vested. In addition, subject to approval of the Orchid
BioScience, Inc. 2005 Stock Plan by the shareholders of the Company, the Company
will grant to the Employee on the date after such shareholder approval incentive
stock options to purchase one hundred thousand (100,000) shares of the Company’s
common stock at an exercise price equal to the closing price of such stock on
the date of grant, all of which options will vest monthly in forty-eight (48)
equal tranches over the four (4) years following the date of grant. The
foregoing stock options shall be subject to the terms and conditions of the
applicable plan and the Company’s standard stock option agreement. In addition,
upon a Change of Control, all unvested options shall become immediately vested.

 

3

--------------------------------------------------------------------------------

(c) Employee shall be entitled to participate in all employee benefit, welfare
and other plans, practices policies and programs and fringe benefits of the
Company on a basis no less favorable than those provided to other similarly
situated executives of the Company. Employee understands that, except when
prohibited by applicable law, the Company’s employee benefit plans and fringe
benefits may be amended, enlarged, diminished or terminated by the Company from
time to time, in its sole discretion.

 

(d) The Company, at its expense, will purchase life insurance on the Employee’s
life in the face amount of not less than three (3) times Employee’s base pay
rate with a beneficiary designated by the Employee and the Employee shall
receive deferred compensation through contributions of five percent (5%) of
Employee’s annual base pay per year in accordance with the terms of the Orchid
BioSciences, Inc. Executive Deferred Compensation Plan.

 

(e) Employee will be entitled to five (5) sick days, and to accrue up to
twenty-five (25) vacation days per year that Employee remains employed by the
Company, subject to the terms of normal Company sick leave and vacation
policies.

 

(f) The Company agrees to reimburse the Employee up to Fifty Thousand Dollars
($50,000) of Relocation Expenses (as defined) relating to his relocation of his
primary residence to within fifty (50) miles of the Company’s Head Office. Such
reimbursement shall be upon presentation of reasonably detailed invoices for
bona fide Relocation Expenses. For purposes hereof, “Relocation Expenses” shall
mean (a) the actual transportation costs for moving Employee’s household goods;
(b) closing costs on a home within fifty (50) miles of the Company’s Head
Office; (c) temporary living expenses within fifty (50) miles of the Company’s
Head Office for up of two (2) months; and (d) two (2) house hunting trips for
Employee, his spouse and daughter. The foregoing notwithstanding, if within
twelve (12) months after the Employee relocates his primary residence Employee
voluntarily terminates his employment with the Company (other than for a
Constructive Dismissal) or his employment with the Company is terminated for
Cause, then Employee shall immediately pay to the Company the amount of the
Relocation Expenses reimbursed to Employee (or the Company may withhold such
amount from any payments otherwise due to Employee). The Company shall only be
obligated to reimburse Employee for Relocation Expenses incurred within twelve
(12) months from the date of this Agreement.

 

(g) The Employee shall be expected to purchase in the open-market either prior
to or within six (6) months after his date of employment with the Company, ten
thousand dollars ($10,000) worth of the common stock of the Company, and provide
evidence thereof of the Vice President, Human Resources.

 

(h) In connection with any travel on business on behalf of the Company,
depending upon the meeting schedule at the destination, and subject to mutual
agreement with respect thereto by the Employee and the Company’s Chief Executive
Officer, for any flight over four (4) hours, the Employee may fly business
class.

 

6. Confidentiality, Inventions and Non-Competition. The Company considers the
protection of its confidential information, proprietary materials and goodwill
to be extremely important. Given the confidential nature of various aspects of
the Company’s business, the Employee may not discuss the fact or terms of this
Agreement or any employment discussions with anyone other than the Chief
Executive Officer, the Vice President, Human Resources or the Vice President,

 

4

--------------------------------------------------------------------------------

Legal Affairs, members of Employee’s immediate family and, if relevant, the
Employee’s financial advisor or lawyer, provided, the Employee acknowledges and
agrees that this Agreement may be publicly disclosed by the Company. In
addition, the Employee agrees to sign and return the attached Employee Agreement
concurrently with the execution of this Agreement.

 

7. Miscellaneous. This Agreement represents the Company’s and Employee’s entire
understanding with respect to the subject matter contained in this Agreement and
supersedes all previous understandings, written or oral, between the Company and
Employee concerning the subject matter of this Agreement. This Agreement may be
amended or modified only in a writing signed by both a duly authorized officer
of the Company and Employee. No oral waiver, amendment or modification shall be
effective under any circumstances whatsoever.

 

8. D&O Insurance. The Company agrees to maintain a director’s and officers’
liability insurance policy covering Employee to the extent the Company provides
such coverage for its other directors and executive officers.

 

9. Governing Law; Severability. This Agreement shall be governed by the law of
the State of Delaware. Should any provisions of this Agreement by held be a
court of law to be illegal, invalid or unenforceable, the legality, validity and
enforceability of the remaining provisions of this Agreement shall not be
affected or impaired thereby.

 

10. Notices. Any notice required or permitted by this Agreement shall be in
writing and shall be delivered as follows with notice deemed given as indicated:
(1) by personal delivery when delivered personally; (2) by overnight courier
upon written verification of receipt; (3) by telecopy or facsimile transmission
upon acknowledgment of receipt of electronic transmission; or (4) by certified
or registered mail, return receipt requested, upon verification of receipt.
Notices to Employee shall be sent to the last known address in the Company’s
records or such other address as Employee may specify in writing. Notices to the
Company shall be sent to the Chief Executive Officer (with a copy to the General
Counsel) or to such other Company representative as the Company may specify in
writing.

 

BY PLACING MY SIGNATURE HEREUNDER, I ACKNOWLEDGE THAT I HAVE READ ALL THE
PROVISIONS OF THIS AGREEMENT AND THAT I AGREE TO ALL OF ITS TERMS.

 

EMPLOYEE:

        Date:  

April 23, 2005

          /s/    RAYMOND J. LAND                         Raymond J. Land

           

Address: 

 

817 Santa Rita Ave

               

Los Altos, CA 94022

The Company

        Date:  

April 25, 2005

      By:   /s/    PAUL J. KELLY                    

Name:

  Paul J. Kelly                 C.E.O.

 

5